{
  "id": 20617004,
  "title": "Pfizer leaps into ‘in vivo’ CAR-T with latest China deal",
  "url": "https://urgent.news/2026/11/18/pfizer-leaps-into-in-vivo-car-t-with-latest-china-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T15:55:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/pfizer-starna-in-vivo-cell-therapy-autoimmune-disease-deal/875018/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The potentially $2.6 billion collaboration puts Pfizer into a competitive race to treat autoimmune conditions by reprogramming cells inside the body.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Pfizer gets into in vivo CAR-T through licensing deal with Starna Therapeutics",
        "url": "https://urgent.news/2026/11/18/pfizer-gets-into-in-vivo-car-t-through-licensing-deal-with-starna",
        "published": "2026-11-18T12:23:46.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}